Elimination of Tumorigenic Human Pluripotent Stem Cells by a Recombinant Lectin-Toxin Fusion Protein

The application of stem-cell-based therapies in regenerative medicine is hindered by the tumorigenic potential of residual human pluripotent stem cells. Previously, we identified a human pluripotent stem-cell-specific lectin probe, called rBC2LCN, by comprehensive glycome analysis using high-density...

Full description

Bibliographic Details
Main Authors: Hiroaki Tateno, Yasuko Onuma, Yuzuru Ito, Fumi Minoshima, Sayoko Saito, Madoka Shimizu, Yasuhiko Aiki, Makoto Asashima, Jun Hirabayashi
Format: Article
Language:English
Published: Elsevier 2015-05-01
Series:Stem Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213671115000727